IPC-402

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIPC-402
Drug Alias NameIP-20.C1IPC-402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsAminopeptidase N inhibitors
TargetsDipeptidyl peptidase IVAminopeptidase N
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImtm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImtm
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A